(19)

(11)

EP 4 823 675 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24837768.1 (22) Date of filing: 12.12.2024

(51) International Patent Classification (IPC):  A61P 5/14(2006.01) C07K 16/28(2006.01) (52) Cooperative Patent Classification (CPC): A61P 5/14; C07K 16/2863; C07K 2317/76; C07K 2317/92; C07K 2317/732; C07K 2317/94 (86) International application number: PCT/US2024/059796 (87) International publication number: WO 2025/128839 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 13.12.2023 US 202363609824 P (71) Applicant: Horizon Therapeutics Ireland DAC Dublin, A96 F2A8 (IE)	(72) Inventors: WARD, Christopher Davidson Dublin, A96 F2A8 (IE) BORROK III, Martin Jack Dublin, A96 F2A8 (IE) (74) Representative: J A Kemp LLP  80 Turnmill Street London EC1M 5QU London EC1M 5QU (GB)